CHANGES OF ACTIVITY INDEX AND TOTAL SEVERITY INDEX IN PATIENTS WITH SYSTEMIC SCLEROSIS AND INTERSTITIAL LUNG DISEASE OVER A 5-YEAR FOLLOW-UP PERIOD
Systemic sclerosis (SS) is a systemic disease, the basis for which is microcirculatory disorders, inflammation, and generalized fibrosis. Interstitial lung disease (ILD) is one of the primary manifestations of SS. Assessment of SS activity and severity is hindered as it is very difficult to differen...
Saved in:
| Main Authors: | O. B. Ovsyannikova, L. P. Ananyeva, V. N. Lesnyak, O. A. Koneva, M. N. Starovoitova, O. V. Desinova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2016-07-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/2226 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE IMPORTANCE OF HIGH-RESOLUTION COMPUTED TOMOGRAPHY IN EVALUATING THE EFFICACY OF RITUXIMAB IN PATIENTS WITH INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS
by: O. A. Koneva, et al.
Published: (2018-11-01) -
Anti-topoisomerase 1 antibody level changes after B сell depletion therapy in systemic sclerosis
by: L. P. Ananyeva, et al.
Published: (2022-03-01) -
Use of the international systemic scleroderma activity index
by: Maya Nikolayevna Starovoitova, et al.
Published: (2013-03-01) -
Use of ultrasound to evaluation interstitial lung disease in rheumatic disease
by: O. B. Ovsyannikova, et al.
Published: (2024-11-01) -
Identification of serum exosome proteins in systemic sclerosis with interstitial lung disease by aptamer proteomics
by: Sonsoles Piera-Velazquez, et al.
Published: (2025-07-01)